SCHEMBL22981314

SCHEMBL22981314

COCc1nn(Cc2ccc3c(c2)CN(C(=O)O)CC3)cc1C(=O)OC

nearest known ligand 0.47

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ F11 P03951 11/20 0.47
▸ KLKB1 P03952 9/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22981213 0.92 F11 (0.45) F11KLKB1
SCHEMBL22982359 0.89 F11 (0.56) F11KLKB1
SCHEMBL29405107 0.89 F11 (0.56) F11KLKB1
SCHEMBL29388404 0.88 NR1H2 (0.49) F11KLKB1
SCHEMBL22993173 0.88 NR1H2 (0.49) F11KLKB1
SCHEMBL29405481 0.86 F11 (0.52) F11KLKB1
SCHEMBL24253253 0.85 KLKB1 (0.47) F11KLKB1
SCHEMBL26227494 0.85 KLKB1 (0.46) F11KLKB1
SCHEMBL22993238 0.82 HDAC1 (0.46) F11KLKB1
Lithium SCHEMBL29407575 0.81 F11 (0.54) F11KLKB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4010333-A1 PLASMA KALLIKREIN INHIBITORS Kalvista Pharmaceuticals Limited (GB) 2022-06-15 — — EP disclosed
WO-2021028645-A1 PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-18 — — WO disclosed
WO-2021028649-A1 PLASMA KALLIKREIN INHIBITORS KALVISTA PHARMACEUTICALS LIMITED (GB) 2021-02-18 — — WO disclosed
Send feedback